Dr. J. Eric Ahlskog, a Consultant in the Department of Neurology at Mayo Clinic in Rochester, MN, discusses his article appearing in the December 2011 issue of Mayo Clinic Proceedings on the effectiveness of treating Parkinson's Disease with carbidopa/levodopa and notes its most effective dosage regimen is tailored to the needs of the patient. Available at: http://www.mayoclinicproceedings.com/content/86/12/1211.full

http://www.biogetica.com - This video discusses the cure controversies across different systems of medicine. Natural medicine systems like Ayurveda and Homeopathy rarely get into the duality of whether a certain ailment can be cured. Allopathy on the other hand often does and lands up in a situation where very few ailments or diseases can be cured. Is it productive or counter-productive to focus on finding cures? Is it better to focus on curing people or keeping them well? IF you were no...

http://www.biogetica.com - This Video discusses how the presence of Anti-bodies is linked to Viruses. Antibodies are created by your body to fight a virus. These specific anti-bodies are tell tale signs of past or present viral infections or vaccinations. Blood tests do not actually detect the virus; instead they look for antibodies (the body's immune response) in the blood. The presence of life long anti-bodies is now used to label viruses as incurable. Once you've had a certain virus you...

Is it possible to cure drug addiction through medicine. This short film experiments with that reality.

Daniele Piomelli, PhD. - Another approach was discussed by D. Piomelli (University of California, Irvine). URB 597, an inhibitor of fatty acid amide hydrolase (FAAH), is expected to increase anandamide signaling and is being currently clinically tested in the therapy of pain. An increase in anandamide signaling may also be useful in the therapy of depression. This is a novel approach to the development of antidepressants. The signaling can be enhanced by blocking anadamide metabolism or by...